QLGN News and Press, Qualigen Therapeutics Inc. From 08/17/21

Gainers: Virpax Pharmaceuticals (NASDAQ:VRPX) +220%. Alfi  (NASDAQ:ALF) +27%. Aerpio Pharmaceuticals  (NASDAQ:ARPO) +26%. Sesen Bio (NASDAQ:SESN) +23%. monday.com (NASDAQ:MNDY) +20%. Eco Wave Power Global AB (publ) (NASDAQ:WAVE) +17%. Terns Pharmaceuticals (NASDAQ:TERN) +15%. Connec...

Gainers: Virpax Pharmaceuticals (NASDAQ:VRPX) +96%, Sesen Bio (NASDAQ:SESN) +28%, Terns Pharmaceuticals (NASDAQ:TERN) +16%, 23andMe (NASDAQ:ME) +16%, NanoVibronix (NASDAQ:NAOV) +9%. Losers: Qualigen Therapeutics (NASDAQ:QLGN) -16%, Sema4 ...

CARLSBAD, Calif.,, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announces its intention to prioritize its focus to its oncology pipeline that includes QN-247 and RAS-F. These plans follow feedback the Company received from the United States Food and Dru...

Oxbridge (OXBR) +57%.Jiuzi (JZXN) +37%.Yunhong CTI (CTIB) +23%.AgriFORCE Growing  (AGRI) +14%.Scienjoy  (SJ) +12%.Qualigen Therapeutics (QLGN) +7%.Powerbridge (PBTS) +9%.China Online Edducation (COE) +8%.Clovis Oncology (CLVS) +8%.Forward Pharma (FWP) +8%.Covanta Holding (CVA) ...

Qualigen Therapeutics (QLGN) pops 7.3% premarket after submitting an Investigational New Drug ((IND)) application to the FDA for Phase 1b/2a clinical trials of QN-165 with an initial target indication of the treatment of hospitalized COVID-19 patients.QN-165, a DNA aptamer, is a bro...

CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today the submission of an Investigational New Drug (IND) application to...

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that according to a preliminary list of additions posted June 4 it...

CARLSBAD, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that its CEO and Chairman Michael Poirier will present and partici...

Qualigen (QLGN) appointed Tariq Arshad, MD, MBA to the newly-created position of Senior Vice President, CMO. Most recently, Dr. Arshad was Global Head of Medical Affairs and Clinical Research for Becton Dickinson BioSciences (BDX) in San Jose, California where he led a team of MDs and PhDs dr...

New Position Created to Deepen Clinical Expertise and Advance Pipeline Therapeutic Programs CARLSBAD, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for t...